Terms: = Kidney tumors AND PSA AND Prognosis
27 results:
1. Clear cell urothelial carcinoma of bladder: Case report of a rare and aggressive variant with review of literature.
Sahetia KM; Dave VN; Pal M; Menon S
Indian J Cancer; 2023 Oct; 60(4):575-577. PubMed ID: 38145907
[TBL] [Abstract] [Full Text] [Related]
2. Exosomal long noncoding RNA HOXD-AS1 promotes prostate cancer metastasis via miR-361-5p/FOXM1 axis.
Jiang Y; Zhao H; Chen Y; Li K; Li T; Chen J; Zhang B; Guo C; Qing L; Shen J; Liu X; Gu P
Cell Death Dis; 2021 Dec; 12(12):1129. PubMed ID: 34864822
[TBL] [Abstract] [Full Text] [Related]
3. TGM4: an immunogenic prostate-restricted antigen.
Lopez-Bujanda ZA; Obradovic A; Nirschl TR; Crowley L; Macedo R; Papachristodoulou A; O'Donnell T; Laserson U; Zarif JC; Reshef R; Yuan T; Soni MK; Antonarakis ES; Haffner MC; Larman HB; Shen MM; Muranski P; Drake CG
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34193566
[TBL] [Abstract] [Full Text] [Related]
4. Primitive small cell carcinoma of the prostate. Case report and revision of the literature.
Pepe P; Pepe L; Curdman M; Pennisi M; Fraggetta F
Arch Ital Urol Androl; 2020 Dec; 92(4):. PubMed ID: 33348972
[TBL] [Abstract] [Full Text] [Related]
5. Prostate cancer in kidney transplant recipients - a nationwide register study.
Bratt O; Drevin L; Prütz KG; Carlsson S; Wennberg L; Stattin P
BJU Int; 2020 May; 125(5):679-685. PubMed ID: 31955497
[TBL] [Abstract] [Full Text] [Related]
6. Development and validation of prognostic nomograms for patients with metastatic prostate cancer.
Jiang WD; Yuan PC
Int Urol Nephrol; 2019 Oct; 51(10):1743-1753. PubMed ID: 31289983
[TBL] [Abstract] [Full Text] [Related]
7. Autoantibody against new gene expressed in prostate protein is traceable in prostate cancer patients.
Mohsenzadegan M; Saebi F; Yazdani M; Abolhasani M; Saemi N; Jahanbani F; Farajollahi MM
Biomark Med; 2018 Oct; 12(10):1125-1138. PubMed ID: 30191737
[TBL] [Abstract] [Full Text] [Related]
8. Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer?
Schnoeller TJ; Steinestel J; Steinestel K; Jentzmik F; Schrader AJ
Int Urol Nephrol; 2015 May; 47(5):765-70. PubMed ID: 25787073
[TBL] [Abstract] [Full Text] [Related]
9. Recognizing and managing comorbidities in psoriatic arthritis.
Ogdie A; Schwartzman S; Husni ME
Curr Opin Rheumatol; 2015 Mar; 27(2):118-26. PubMed ID: 25603040
[TBL] [Abstract] [Full Text] [Related]
10. CD117⁺ cells in the circulation are predictive of advanced prostate cancer.
Kerr BA; Miocinovic R; Smith AK; West XZ; Watts KE; Alzayed AW; Klink JC; Mir MC; Sturey T; Hansel DE; Heston WD; Stephenson AJ; Klein EA; Byzova TV
Oncotarget; 2015 Jan; 6(3):1889-97. PubMed ID: 25595903
[TBL] [Abstract] [Full Text] [Related]
11. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract] [Full Text] [Related]
12. [Radical cancer surgery of renal cell and prostate carcinoma with hematogenous metastasis: benefits].
Heidenreich A; Pfister D; Porres D
Urologe A; 2014 Jun; 53(6):823-31. PubMed ID: 24824471
[TBL] [Abstract] [Full Text] [Related]
13. Urological tumors in renal transplantation.
Tillou X; Doerfler A
Minerva Urol Nefrol; 2014 Mar; 66(1):57-67. PubMed ID: 24721941
[TBL] [Abstract] [Full Text] [Related]
14. [Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies].
Köhler A; Eggers H; Kuczyk MA; Schrader AJ; Steffens S
Aktuelle Urol; 2013 Nov; 44(6):452-5. PubMed ID: 24258396
[TBL] [Abstract] [Full Text] [Related]
15. [Villous adenoma of the urinary tract: a clinicopathological study].
Yin W; Mo XL; Wen ZH; Zhou XZ; Zhou MY; Wei HM
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):438-41. PubMed ID: 24246860
[TBL] [Abstract] [Full Text] [Related]
16. The utility of psa velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
[TBL] [Abstract] [Full Text] [Related]
17. The impact of peptidase activity on clear cell renal cell carcinoma survival.
Larrinaga G; Blanco L; Sanz B; Perez I; Gil J; Unda M; Andrés L; Casis L; López JI
Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1584-91. PubMed ID: 23019229
[TBL] [Abstract] [Full Text] [Related]
18. Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?
Patel AR; Stephenson AJ
Nat Rev Urol; 2011 Jun; 8(7):385-92. PubMed ID: 21670752
[TBL] [Abstract] [Full Text] [Related]
19. Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.
Walz J; Joniau S; Chun FK; Isbarn H; Jeldres C; Yossepowitch O; Chao-Yu H; Klein EA; Scardino PT; Reuther A; Poppel HV; Graefen M; Huland H; Karakiewicz PI
BJU Int; 2011 Mar; 107(5):765-770. PubMed ID: 20875089
[TBL] [Abstract] [Full Text] [Related]
20. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
Stephenson AJ; Kattan MW; Eastham JA; Bianco FJ; Yossepowitch O; Vickers AJ; Klein EA; Wood DP; Scardino PT
J Clin Oncol; 2009 Sep; 27(26):4300-5. PubMed ID: 19636023
[TBL] [Abstract] [Full Text] [Related]
[Next]
